Ferrari North America, Inc.
Summary
NHTSA campaign 22V536: Ferrari North America, Inc. recalled for a safety defect. A loss of brake function can increase the risk of a crash.
Details
Source
nhtsa
External ID
22V536
Action Date
2022-07-26
Status
Ongoing
Category
vehicle
Product Description
Ferrari North America, Inc. (Ferrari) is recalling certain 2005-2009 430, 2019-2020 488 Pista, 2016 F60 America, 2005-2011 612 Scaglietti, 2010-2011 612, 2018-2022 812, 2020-2022 F8 Spider, 2020-2022 F8 Tributo, 2021-2022 Roma, 2009-2017 California, 2015-2017 California T, 2013-2017 F12 Berlinetta, 2017 F12 TDF, 2012-2016 FF, 2017-2020 GTC4 Lusso, 2018-2020 GTC4 Lusso T, 2013-2015 LaFerrari, 2017 LaFerrari Aperta, and 2019-2022 Portofino vehicles. The brake fluid reservoir cap may not vent properly, creating a vacuum inside the brake fluid reservoir, and resulting in a brake fluid leak that may lead to a partial or total loss of brake function.
Company
Context & Analysis
Ferrari North America, Inc. has 8 FDA actions in our database.
Frequently Asked Questions
How often does Ferrari North America, Inc. have FDA actions?
Ferrari North America, Inc. has 8 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle